Skip to main content
Caplight Logo









PAN Biologics

PAN Biologics

Private
Knoxville, TennesseeHealthcare & Life Scienceshttps://panbiologics.online/

Last Round

Grant

Jul 20, 2026

Total Funding Raised

$25,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PAN Biologics is a biotechnology company that develops a unified bioengineering platform for functional diagnostics and targeted therapeutics in oncology and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologypeptide therapeuticstargeted alpha therapyradioligand therapyprecision medicinedrug discoverybioengineeringfunctional diagnosticsoncologydrug screeningplant immunitycrop protectionbiotech startuptherapeuticsactinium-225

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PAN Biologics Comparables

Compare PAN Biologics with similar companies based on industry and business-model similarity.

PAN Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orion Therapeutics
70%
AstraZeneca
68%
Novartis
65%

PAN Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 20, 2026
GrantJul 1, 2025
GrantNov 18, 2024

PAN Biologics Investors

Notable investors and investment history

PAN Biologics investors
InvestorRounds
TAEBCGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    $15K raised from Spark Innovation Center and TAEBC.

  • Jul 1, 2025

    $10K raised from LifeSciKY and McD Concrete Enterprises.

Recent news

Latest coverage and updates

  • is_developingOct 9, 2026

    PAN Biologics is developing a cancer therapy applied to the PAN domain

PAN Biologics Filings

Explore SEC and related filing metadata, where available.

PAN Biologics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PAN Biologics's valuation, stock price, and market status.

Is PAN Biologics a public or private company?

PAN Biologics is a private company.

What is the current stock price of PAN Biologics?

PAN Biologics is a private company with no public stock price. Caplight tracks PAN Biologics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PAN Biologics worth (valuation)?

Valuation information for PAN Biologics is not publicly available.

Can I buy PAN Biologics stock?

PAN Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PAN Biologics's last funding round?

PAN Biologics's most recent funding round was Grant on July 20, 2026.

Who are the main investors in PAN Biologics?

Key investors in PAN Biologics include TAEBC.

Will PAN Biologics IPO soon?

No public IPO plans have been announced for PAN Biologics.

How can I track PAN Biologics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PAN Biologics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKnoxville, Tennessee
Employee Range1
Year Founded2024
Last FundingJul 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?